Clinical trial
Developmental Pharmacokinetics of Psychotropic Drugs: Olanzapine
NCT00183612 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Developmental Pharmacokinetics of Psychotropic Drugs: Olanzapine
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 31, 2000
- Completion date
- April 30, 2007
- Enrollment
- 68
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.